Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asacol Once Daily vs Divided Doses in Ulcerative Colitis Maintenance
NCT00708656Phase 3Completed
- Sponsor
- Cardiff and Vale University Health Board
- Start
- Oct 2006
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of Salcrozine in ulcerative colitis (UC) (2 arms), sponsored by Cardiff and Vale University Health Board. Primary endpoint: Relapse rate at 1 year. Started Oct 2006; status: completed.
02
Drugs
Salcrozine
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00708656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00708656.